Infectious Diseases Working Party (IDWP)
Type d'étude:
Numéro de l'étude:
8414113
Type de traitement:
Maladies:
Myelodysplastic (MDS) or MDS/MPN
Acute Myeloid Leukaemia (AML)
Acute Lymphatic Leukaemia (ALL)
Titre court:
IPAT study
Objectif principal:
to determine if pre-existing IA influences non-relapse mortality after allo-HSCT
Principaux critères d'inclusion:
first allo in patients with AL or MDS
Pays:
Investigateur principal:
Olaf Penack
E-mail du coordinateur de l'étude:
idwp.ebmt@lumc.nl